Casdin Capital, LLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 10:23 am Purchase |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Casdin Capital, LLC | 1,241,176 4.520% |
1,891 (+0.15%) |
Filing |